000 01846 a2200505 4500
005 20250513120723.0
264 0 _c19970605
008 199706s 0 0 eng d
022 _a1042-8194
024 7 _a10.3109/10428199609093433
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMatherly, L H
245 0 0 _aMethotrexate pharmacology and resistance in childhood acute lymphoblastic leukemia.
_h[electronic resource]
260 _bLeukemia & lymphoma
_cMay 1996
300 _a359-68 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAdult
650 0 4 _aAntimetabolites, Antineoplastic
_xpharmacokinetics
650 0 4 _aBiological Transport
650 0 4 _aBiotransformation
650 0 4 _aCarrier Proteins
_xmetabolism
650 0 4 _aChild
650 0 4 _aChromosomes, Human, Pair 21
_xgenetics
650 0 4 _aDisease Susceptibility
650 0 4 _aDisease-Free Survival
650 0 4 _aDown Syndrome
_xcomplications
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aFolic Acid Antagonists
_xpharmacokinetics
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aMembrane Proteins
650 0 4 _aMembrane Transport Proteins
650 0 4 _aMethotrexate
_xpharmacokinetics
650 0 4 _aNeoplasm Proteins
_xmetabolism
650 0 4 _aNeoplastic Stem Cells
_xmetabolism
650 0 4 _aPolyglutamic Acid
_xmetabolism
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xdrug therapy
650 0 4 _aPrognosis
650 0 4 _aReduced Folate Carrier Protein
650 0 4 _aRemission Induction
650 0 4 _aTetrahydrofolate Dehydrogenase
_xmetabolism
700 1 _aTaub, J W
773 0 _tLeukemia & lymphoma
_gvol. 21
_gno. 5-6
_gp. 359-68
856 4 0 _uhttps://doi.org/10.3109/10428199609093433
_zAvailable from publisher's website
999 _c9153912
_d9153912